Ovarian Cancer

Availing best possible medical treatment through JCI & US accredited hospital which meets the standard of international hospitals. The hospitals of ovarian cancer surgery are equipped with some of the most advanced facilities in the world ...  

For the first time, professionals are identifying ovarian cancer symptoms and explains what women, and their doctors, should be on the alert for. Your Cancer Today interviews Dr. Barbara Goff, Director of the Gynecologic Cancer Divi...  

All ovarian cancers are not the same, and a new study suggests gene testing of ovarian tumors may soon allow for more personalized and effective ovarian cancer treatment.  

A multi-institutional study has identified a potential personalized treatment target for the most common form of ovarian cancer. The research team discovered that a gene called MAGP2 -- not previously associated with any type of cancer -- was overexpressed in papillary serous ovarian tumors of patients who died more quickly. They also found evidence suggesting possible mechanisms by which MAGP2 may promote tumor growth.  

Around 1.5 percent of women are likely to develop ovarian cancer at some stage of their life. It is less common than breast cancer but is considered as the most serious and fatal of all gynecological cancers. The reason for this is that the cancer is u...  

Do you find yourself searching for facts about ovarian cancer? Well here are a couple quick facts for you. The ovaries belong to the female reproductive system and produce eggs each month during the reproductive years of a woman. You will fin...  

HOUSTON, Dec. 17 /PRNewswire-FirstCall/ -- John Howell, CEO of Arrayit Diagnostics, Inc., a majority-owned subsidiary of Arrayit Corporation (OTC Bulletin Board: ARYC), today formally commented on the anticipated timeline for commercialization of its microarray-based OvaDx(TM) Pre-Symptomatic Ovarian Cancer Blood Test, which is currently advancing through late-stage development - the rights to which have been assigned exclusively to the...  

Talcum Powder and Ovarian Cancer LEARN MORE Cancer Prevention Coalition Web site CPC - 1994 Letter to FDA over dangers of Talc Products Harvard University - Study on talcum powder, 2008 American Cancer society National Cancer Institute on Ovarian Cancer IMAGE SOURCE: Female reproductive system graphic/ National Cancer Institute Web site Talc is the world's softest rock used to make a variety of ...  

Background: Liposomal doxorubicin (Doxil) is a cytotoxic chemotherapy drug with a favorable hematologic toxicity profile. Its active drug, doxorubicin, has interesting immunomodulatory properties. Here, the effects of Doxil on surviving tumor cell immunophenotype were investigated. Methods: Using ID8 murine ovarian cancer cells, the immunomodulatory effects of Doxil were studied by measuring its impact on ovarian cancer cell expression of MHC...  

The hedgehog (Hh) signaling pathway regulates many processes of development and tissue homeostasis. Activation of hedgehog signaling has been reported in about 30% of human cancer including ovarian cancer. Inhibition of hedgehog signaling has been pursued as an effective strategy for cancer treatment including an ongoing phase II clinical trial in ovarian cancer. However, the rate of hedgehog signaling activation in ovarian cancer was reported...  

New Treatment Could Allow Ovarian Cancer Patients to Keep Having ChildrenKEYCIn Health Watch:For many young women, an ovarian cancer diagnosis can make having children impossible.But now new research shows there may be options. ...More choices for women with ovarian cancer, say researchersKENS 5 TVOvarian Cancer Op Doesn't Have To End FertilityWBZall 3 news articles »  

http://www.companiesandmarkets.com/Summary-Market-Report/cancer-ovarian-cancer-therapy-area-pipeline-report-188078.asp The Ovarian Cancer Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of ovarian cancer drugs by company and by stage as well as a summary of the latest news and developments in this area. Scope of the report: Each Therapy Area...  

A woman who was constantly approached by strangers asking ... other women with ovarian cysts who have been misdiagnosed Mrs Delaney now has to have blood tests every six months to check for cancer, and so far they have come back clear.  

Women with endometriosis have a higher prevalence of recurrent upper respiratory or vaginal infections, melanoma, and ovarian cancer compared with women in the general population, according to a paper published online November 27 in Fertility and Sterility. Reuters Health Information  

FREMONT, Calif., Nov. 12 /PRNewswire-FirstCall/ -- Vermillion, Inc. (OTC: VRMLQ.PK), a molecular diagnostics company, today announced that the U.S. Patent Office (USPTO) has issued patent number 7,605,003 titled "Use of biomarkers for detecting ovarian cancer" to the Company for the discovery of biomarkers for ovarian cancer. The patent covers biomarker combinations for both the diagnosis and management of ovarian cancer and covers measurement...